Co-stimulatory molecules in islet xenotransplantation: CTLA4Ig treatment in CD40 ligand-deficient mice

Cell Transplantation

Volumn 11, Issue 7, 2002, Pages 715-720

  Benda, Birgitta ^a   Ljunggren, Hans Gustaf ^b   Peach, Robert ^c   Sandberg, Jan Olov ^d   Korsgren, Olle ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

^d Roche AB   (Sweden)

Author keywords

CD40L; Co stimulation; CTLA4Ig; In vivo animal model; Islet; Xenotransplantation

Indexed keywords

CD28 ANTIGEN; CD40 LIGAND; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MODEL; CONTROLLED STUDY; DRUG ACTIVITY; GRAFT PRESERVATION; GRAFT REJECTION; GRAFT SURVIVAL; MOUSE; MOUSE STRAIN; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SWINE; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 12244278989     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000002783985440     Document Type: Article

References (23)

1. Elwood, E. T.; Larsen, C. P.; Cho, H. R.; Corbascio, M.; Ritchie, S. C.; Alexander, D. Z.; Tucker-Burden, C.; Linsley, P. S.; Aruffo, A.; Hollenbaugh, D.; Winn, K. J.; Pearson, T. C. Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockade. Transplantation. 65:1422-1428; 1998.
2. Gordon, E. J.; Markees, T. G.; Phillips, N. E.; Noelle, R. J.; Shultz, L. D.; Mordes, J. P.; Rossini, A. A.; Greiner, D. L. Prolonged survival of rat islet and skin xenografts in mice treated with donor splenocytes and anti-CD154 monoclonal antibody. Diabetes. 47:1199-1206; 1998.
3. Grewal, I. S.; Foellmer, H. G.; Grewal, K. D.; Xu, J.; Hardardottir, F.; Baron, J. L.; Janeway, C. A., Jr.; Flavell, R. A. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 273:1864-1867; 1996.
4. Grewal, I. S.; Xu, J.; Flavell, R. A. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378:617-620; 1995.
5. Korsgren, O.; Andersson, A.; Sandler, S. Pretreatment of fetal porcine pancreas in culture with nicotinamide accelerates reversal of diabetes after transplantation to nude mice. Surgery 113:205-214; 1993.
6. Korsgren, O.; Jansson, L.; Sandler, S.; Andersson, A. Hyperglycemia-induced B cell toxicity. J. Clin. Invest. 86: 2161-2168; 1990.
7. Koulmanda, M.; Kovarik, J.; Mandel, T. E. Cyclophosphamide, but not CTLA4Ig, prolongs survival of fetal pig islet grafts in anti-T cell monoclonal antibody-treated NOD mice. Xenotransplantation 5:215-221; 1998.
8. Lenschow, D. J.; Zeng, Y.; Thistlethwaite, J. R.; Montag, A.; Brady, W.; Gibson, M. G.; Linsley, P. S.; Bluestone, J. A. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257:789-792; 1992.
9. Linsley, P. S.; Brady, W.; Urnes, M.; Grosmaire, L. S.; Damle, N. K.; Ledbetter, J. A. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174: 561-569; 1991.
10. Linsley, P. S.; Greene, J. L.; Brady, W.; Bajorath, J.; Ledbetter, J. A.; Peach, R. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1:793-801; 1994.
11. Linsley, P. S.; Wallace, P. M.; Johnson, J.; Gibson, M. G.; Greene, J. A. L.; Ledbetter, J. A.; Singh, C.; Tepper, M. A. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257:792-795; 1992.
12. Liu, Y.; Jones, B.; Brady, W.; Janeway, C. A., Jr.; Linsley, P. S. Co-stimulation of murine CD4 T cell growth: Cooperation between B7 and heat-stable antigen. Eur. J. Immunol. 22:2855-2859; 1992.
13. Lu, P.; Wang, Y. L.; Linsley, P. S. Regulation of self-tolerance by CD80/CD86 interactions. Curr. Opin. Immunol. 9:858-862; 1997.
14. Maher, S. E.; Karmann, K.; Min, W.; Hughes, C. C. W.; Pober, J. S.; Bothwell, A. L. M. Porcine endothelial CD86 is a major costimulator of xenogeneic human T cells. J. Immunol. 157:3838-3844; 1996.
15. Markees, T. G.; Appel, M. C.; Noelle, R. J.; Mordes, J. P.; Greiner, D. L.; Rossini, A. A. Tolerance to islet xenografts induced by dual manipulation of antigen presentation and co-stimulation. Transplant. Proc. 28:814-815; 1996.
16. Murray, A. G.; Khodadoust, M. M.; Pober, J. S.; Bothwell, A. L. M. Porcine aortic endothelial cells activate human T cells: Direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity 1:57-63; 1994.
17. Rogers, N. J.; Mirenda, V.; Jackson, I.; Dorling, A.; Lechler, R. I. Costimulatory blockade by the induction of an endogenous xenospecific antibody response. Nat. Immunol. 2:163-168; 2000.
18. Shoskes, D. A.; Wood, K. J. Indirect presentation of MHC antigens in transplantation. Immunol. Today 15:32-38; 1994.
19. Tran, H. M.; Nickerson, P. W.; Patel, A.; Strom, T. B.; Allen, R. D. M.; O'Connell, P. J. Short-term suppression of the xeno-immune response with mCTLA4-Fc treatment. Xenotransplantation 4:222-227; 1997.
20. Tran, H. M.; Nickerson, P. W.; Restifo, A. C.; Ivis-Woodward, M. A.; Patel, A.; Allen, R. D.; Strom, T. B.; O'Connell, P. J. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment. J. Immunol. 159:2232-2239; 1997.
21. Weber, C. J.; Hagler, M. K.; Chryssochoos, J. T.; Kapp, J. A.; Korbutt, G. S.; Rajotte, R. V.; Linsley, P. S. CTLA4-Ig prolongs survival of microencapsulated neonatal porcine islet xenografts in diabetic NOD mice. Cell Transplant. 6:505-508; 1997.
22. Wolf, L. A.; Coulombe, M.; Gill, R. G. Donor antigen-presenting cell-independent rejection of islet xenografts. Transplantation 60:1164-1170; 1995.
23. Xu, J.; Foy, T. M.; Laman, J. D.; Elliott, E. A.; Dunn, J. J.; Waldschmidt, T. J.; Elsemore, J.; Noelle, R. J.; Flavell, R. A. Mice deficient for the CD40 ligand. Immunity 1:423-431; 1994.